This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnering Summit
May 17-19, 2022
Delivered as a Hybrid EventRevere Hotel Boston Common • Boston, MA
Book Now
Menu
Book

Eva Temkin
Partner, FDA and Life Sciences at King & Spalding

Agenda Sessions

  • PANEL ● Risks and Rewards of Rare Disease Drug Development — Highlight Opportunities and the Way Forward

    , 11:45am
    View Session

Speakers at this event

Prev
Next
Scott Williams
Head, Global Public Affairs, Rare Diseases and Rare Blood Disorders
Sanofi Genzyme

See Eva Speak

Book Now